Immunology of Inflammatory Diseases of the Bowel

Immunology of Inflammatory Diseases of the Bowel

IMMUNOLOGY 0749--{)720/01 $15.00 + .00 IMMUNOLOGY OF INFLAMMATORY DISEASES OF THE BOWEL W. Ray Waters, DVM, PhD Over the past century, we have se...

10MB Sizes 0 Downloads 4 Views


0749--{)720/01 $15.00




Over the past century, we have seen great advances in the discovery of disease etiologies and pathogenesis. We have also learned that many diseases are complex, and definitions of pathogenesis based simply on pathogen virulence do not always explain disease progression. A preeminent example of this complexity is the role of Helicobacter species in peptic ulcer disease of humans. Helicobacter pylori infection, although usually asymptomatic, may induce gastritis with damage resulting from both pathogen- and host-mediated factors. The discovery of this disease etiology and associated host response has redefined the treatment of gastritis of humans. Likewise, valuable new insights into the pathogenesis of intestinal diseases of animals are being discovered rapidly. Thus, it is of importance as practitioners to develop an integrated view of disease pathogenesis, considering pathogen virulence factors and host responses. In this article, the author has attempted to describe the hosts' contributions to inflammatory diseases of the bowel. It is hoped that these ideas will foster new ideas in intestinal disease management. Inflammation is the progression of vascular changes in response to injury leading to accumulation of fluids and leukocytes in the extracellular space. 14, 17 Endothelial cell activation leads to an increased permeabil-

All material in this article is in the public domain with the exception of any borrowed figures.

From the US Department of Agriculture, Agricultural Research Service, National Animal Disease Center, Bacterial Diseases of Livestock Unit, Ames, Iowa





ity of capillaries and venules, resulting in leakage of fluids and leukocytes from these small vessels. Trauma, toxins, or chemical mediators such as cytokines, histamine, leukotrienes, and bradykinins elicit activation of endothelial cells. Although inflammation is fundamentally a protective response, excessive inflammation may result in hypersensitivity, fibrosis, or other harmful reactions. Within the intestinal mucosa, a physiologic steady state between reactivity to luminal antigens and downregulation of inflammation provides protection and gut homeostasis, respectively. Stimulation with certain microbes and their toxins may alter this balance, resulting in inflammatory diseases of the bowel. IMMUNOBIOLOGY OF THE INTESTINAL TRACT

The intestinal mucosa has two opposing functions, uptake of nutrients and exclusion of pathogens. Ideally, potential pathogens never cross the epithelial barrier. Mechanisms used to exclude pathogens include degradative enzymatic activity, an electrostatically charged glycocalyx, luminal flow, a harsh gastric pH, competition for nutrients and receptors, elaboration of cryptidins and lysozyme by Paneth cells, and adaptive immune responses. The intestinal epithelium, whose main function is to absorb nutrients and secrete degradative enzymes, is also a first line of defense against many enteric pathogens. In addition to their nutritive functions, epithelial cells provide a physical barrier to pathogens and are an important component of the innate immune system. 79 These nonclassical immune cells express major histocompatibility class (MHC) I and II antigens and receptors (Toll-like) on their surface that enable them to detect bacterial products and initiate a host response by secretion of chemokines that recruit leukocytes, especially lymphocytes. 13, 44 Resident and recruited lymphocytes recognize foreign antigen in association with MHC or nonclassical antigen presentation molecules on epithelial cells, thereby linking innate and adaptive immune responses at the onset of microbial invasion of the intestines. Cells other than leukocytes provide repair and resistance mechanisms. Neural cells produce chemical mediators (e.g., neurokinins) that induce inflammation and increase gut peristalsis. Epithelial cells and fibroblasts produce growth factors and cytokines that induce inflammation and repair of damaged mucosal tissues, with repair generally preceded by tissue destruction and remodeling. Transforming growth factor-~ (TGF-~), secreted by mononuclear cells and platelets, activates fibroblasts and other connective tissue cells to produce collagen and matrix proteins. TGF-~, a potent immunosuppressive cytokine, also has a role in dampening inflammation within the gut. Although TGF-~ is key for repair, the suppressive effects of this cytokine may allow persistence of certain microorganisms such as Mycobacterium avium subsp. paratuberculosis, the causative agent of Johne's disease. 66 Other growth factors such as epidermal growth factor and keratinocyte growth factor stimulate epithelial cell proliferation, leading to repair of damaged intes-



tinal surfaces. lo Epithelial cell replacement is obviously an important component of healing for infections that induce epithelial cell damage and loss. Although repair mechanisms may be elicited by direct interaction with the insulting agent, they are often mediated by factors elaborated by mononuclear cells (e.g., cytokines and growth factors). Therefore, the intimate interaction between immune and nonclassical immune cells is necessary for the maintenance of homeostasis within the intestinal tract. Studies with experimental models of inflammatory bowel disease (IBO) have demonstrated that inflammation within the gut often results from a dysregulation of the balance between chronic activation of the mucosal immune system and suppressed reactivity to autoantigens. 64 Intestinal integrity is maintained at the level of the epithelial ce1l32 and by production of nonspecific antimicrobial peptides. 42 Disruption of either adhesion molecules that ensure a normal turnover rate of intestinal epithelial cells or intestinal trefoil factor (a nonspecific antimicrobial peptide) results in loss of intestinal epithelial integrity and ensuing tissue changes (e.g., IBO of humans). Loss of intestinal epithelial integrity (leading to IBO) may also result from either antigen-specific reactivity with cross reactivity directed to autoantigens or from bystander inflammatory processes directed at removal of pathogens. IBO of humans is characterized by two diseases of unknown cause, Crohn's disease and ulcerative colitis. 17 Although both diseases are considered entities of IBO, the causes of these two diseases remain unresolved. Because food animals rarely exhibit IBO as occurs in humans, this article focuses on immune mechanisms of inflammation in food animals caused by enteric pathogens. MUCOSAL IMMUNOLOGY OF THE INTESTINAL TRACT

Adaptive immune responses of intestinal lymphocytes to foreign antigen result in either tolerance to the antigen or a response directed at eliminating the antigen. Although tolerance is a state of specific nonreactivity, it is still defined as an adaptive immune response. Indeed, loss of tolerance often leads to excessive inflammation. Specific reactivity directed at eliminating the pathogen is evoked either before invasion (e.g., immune exclusion) or after invasion (e.g., immune elimination). Secretory immunoglobulin (Ig) A produced by B cells within the intestinal mucosa and secreted into the intestinal lumen provides a specific mechanism of immune exclusion without inflammation. Mucosally derived IgA is not, however, limited to activity within the intestinal lumen. During transcytosis to the apical surface of the epithelial cell, IgA can bind proteins within endosomes where low pH exposes novel pathogenassociated antigens not exposed extracellularly.u Conversely, responses that are directed at eliminating pathogens once they have invaded the intestinal mucosa often lead to inflammation. In addition to clearance of the invading organism, these inflammatory responses may lead to loss



of tolerance to commonly encountered luminal antigens (e.g., normal gut flora or food antigens) and excessive tissue injury. Indeed, several mutant strains of mice that spontaneously develop IBD fail to develop disease when they are raised in a germ-free environment. 52, 59 Additionally, mice with a defined flora (e.g., modified Schaedler's flora) infected with the porcine pathogen Brachyspira hyodysenteriae develop serum antibody responses to commensal bacteria of the intestinal tract, whereas control, noninfected mice do not (Michael J. Wannemuehler, PhD, personal communication, 2000). Likewise, infection of gnotobiotic pigs with B. hyodysenteriae does not induce intestinal inflammatory lesions as seen with conventionally reared pigs. 76 Lesion formation is likely dependent on inflammatory responses directed at otherwise harmless commensal bacteria. Thus, intestinal inflammatory responses may be evoked by invasion of pathogens (e.g., Salmonella sp., rotavirus, coronavirus, helminths, and so forth) or as a result of an aberrant immune response to commensal bacteria (e.g., swine dysentery). Immune reactivity to food antigens, although uncommon with foodproducing animals, may also occur. Certain calves fed a soybean milk replacer developed a hypersensitive response to soy proteins, resulting in intestinal inflammation. 35,67 Similar reactions to soy proteins are described for early weaned pigs. 18 Thus, as with humans, loss of tolerance or a failure to establish tolerance to commensal microbes and to food antigens may lead to inflammatory diseases of the bowel of food animals. As stated previously, foreign antigens traversing the intestinal epithelial barrier evoke either tolerance or inflammation. Antigens may also be actively sampled from the intestinal lumen. Specialized epithelial cells, microfold or M cells, pinocytose luminal antigens. These antigens are delivered intact to antigen-presenting cells, B cells, and macrophages stationed within basilar folds of M cells (Fig. 1). Antigen-presenting cells then deliver the antigens to Peyer's patches and other lymphoid aggregates. Antigens are processed and presented in association with MHC molecules for o:~ T cells or intact without processing for B cells or ~'6 T cells. o:~ T cells express 0: and ~ T-cell receptor chains on their surfaces, whereas ~'6 T cells express ~ and '6 T-cell receptor chains on their surfaces. o:~ T cells are well-characterized T cells, whereas ~'6 T cells are a less-characterized subset of T cells. ~'6 T cells are often associated with epithelial surfaces and are considered a first line of defense against invading pathogens. 29 Higher percentages of ~'6 T cells are detected within the peripheral blood of cattle and pigs as compared with percentages within the peripheral blood of humans and rodents. 31 Both T and B cells recognizing antigen delivered from M cells proliferate and produce cytokines or become cytotoxic (T cells) or produce antibody (B cells). Progeny of these antigen-specific intestinallymphocytes often traffic to other mucosal areas through the systemic circulation (e.g., common mucosal immune system). Therefore, B cells originating within the intestinal mucosa may eventually localize in the




Figure 1. An M (microfold) cell. Lymphocytes and macrophages migrate into the invagination of the basolateral surface of M cells and sample endocytosed antigens that have been transported into the basolateral pocket via vesicles. The apical surface of M cells lacks closely packed microvilli and the enzyme-rich coat of absorptive enterocytes yet efficiently binds and transports microorganisms, particles, and antigens to underlying antigen-presenting cells. (Adapted from Neutra MR, Kraehenbuhl JP: The role of transepithelial transport by M cells in microbial invasion and host defense. J Cell Science 17:209-215, 1993; with permission from Company of Biologists Ltd.)

mammary gland and secrete antibody into milk, providing lactogenic immunity to newborns. The type of antigen presented, responding cell type, and local environment contribute to the nature of an ensuing response. For instance, a porcine B cell specific for Escherichia coli shigatoxin likely produces shiga toxin-specific secretory IgA if it encounters its specific antigen in a TGF-(3, interleukin (IL)-5 rich environment (e.g., the intestinal mucosa).60 Conversely, certain mycobacterial antigens, especially if encountered early in the course of a Mycobacterium spp. infection of cattle, often induce interferon (lFN)-)' production by T cells resulting in a predominant IgG2 response by B cells. With the Mycobacterium example, the nature of the antigen evoked an IFN-)' /IgG 2 response, whereas with the porcine shiga toxin example, the environment of the gut mucosa biased the response to IgA production. Because the gut mucosa is under constant antigenic stimulation, it is not surprising that the overall bias of the cytokines produced within the gut mucosa favor a less inflammatory outcome (e.g., IL-lO, TGF-(3, IL-5).7, 41, 63 A constant barrage of inflammatory responses at gut mucosal surfaces would compromise intestinal metabolic function. Indeed, it is postulated that an overactive Th 1 (e.g., IFN-)" IL-12) response may be the mechanism underlying the development of chronic intestinal inflammation in multiple models of IBD.59




Proinflammatory or acute-phase cytokines are produced by mononuclear cells (IL-l, IL-6, and tumor necrosis factor [TNF]-a) and epithelial cells (IL-l and IL-6) of the intestinal mucosa in response to bacterial cell wall products (e.g., lipopolysaccharide, muramyl dipeptide, and (3glucan) or other mediators of inflammation (e.g., toxins and superantigens). Genes for these cytokines are consistently upregulated in the intestinal mucosa of human IBD patients. 62 Transient increases in production of acute-phase cytokines within domestic animals infected with various pathogens have also been described. 26, 58, 71 Experimental infection with the porcine enteric pathogens, Salmonella typhimurium or Brachyspira hyodysenteriae, or administration of Clostridium perfringens enterotoxin induces increased serum levels of TNF-a as compared with serum levels of TNF-a in control animals. Chronic enteric disease of domestic animals may also evoke a sustained acute-phase response. For instance, mononuclear cells isolated from cattle with subclinical Johne's disease produce greater amounts of TNF-a as compared with amounts from cattle with clinical paratuberculosis or with amounts from noninfected cattle. 57 The TNF-a response by mononuclear cells from subclinically affected cattle likely reflects a predominance of a cell-mediated, IFN-)' response. Mycobacterium avium subsp. paratuberculosis (M. para) organisms also stimulate production of IL-l and IL-6 in vitro (e.g., by isolated peripheral blood mononuclear cells) and in vivo (e.g., by cells located within the intestinal mucosa).3,4 Induction of acute-phase cytokine responses by enteric pathogens of food animals is not surprising, as it is likely that any ensuing inflammation is a direct result of IL-l, IL6, and TNF-a production. The combined effects of the acute-phase cytokines mentioned above and other inflammatory mediators such as eicosanoids, nitric oxide, and neuropeptides released in response to enteric infections contribute to a local and systemic inflammatory response. Macrophages stimulated by bacterial products produce IL-l, IL-6, and TNF-a. These cytokines activate vascular endothelium, increasing permeability of small blood vessels. Increased vascular permeability leads to leakage of cells and serum containing antibody and complement proteins. IL-l, in addition to its actions on vascular endothelium, activates leukocytes and is responsible for the induction of fever. IL-l and IL-6 can reduce appetite. IL-6 is also important for the activation of B cells for the production of antibody. Excessive production of proinflammatory cytokines, especially TNF-a, leads to cachexia or shock. Although excessive responses are detrimental, regulated acute-phase responses are essential for prompt activation of innate and specific immune reactions. Chronic infection of cattle with M. para results in a remarkable influx of macrophages into the gut mucosa (Fig. 2). This influx of macrophages is especially remarkable in that other obvious indications of inflammation (e.g., edema, neutrophilic infiltrates, or crypt abscesses) are lacking. As stated previously, however, the response to M. para antigens at specific stages of disease includes the induction of acute-



Figure 2. Section of ileum from an adult cow with clinical Johne's disease. The histologic section was stained by the Ziehl-Neelson method to detect acid-fast organisms (stained dark). The arrow points to macrophages infected with M. avium subsp. paratuberculosis (original magnification x 16). (Courtesy of Mitchell V. Palmer, DVM, PhD, and Judith R. Stabel, PhD, National Animal Disease Center, Ames, IA.)

phase cytokines. Cattle with subclinical disease and sheep or goats with tuberculoid-type lesions have a significant proinflammatory cytokine response, whereas cattle with clinical disease do not display a significant proinflammatory cytokine response. 3 • 4, 57 Lesions associated with endstage paratuberculosis lack the associated histologic changes (e.g., edema and neutrophilic infiltrates) indicative of an active inflammatory response (e.g., IL-l, IL-6, and TNF-ex production) . It is likely that this organism (or chronic infection with this organism) induces cytokines such as TGF-j3 or IL-IO that suppress inflammation later in the course of disease. The outcome is an environment in which numerous macrophages are present for the mycobacterium to reside within; yet inflammatory mediators necessary to activate macrophages to kill the bacilli are not produced. In this case, suppression of proinflammatory cytokines leads to an inability of the host to clear the pathogen. In sharp contrast to paratuberculosis, infection of young pigs with the spirochete B. hyodysenteriae results in acute colitis mediated by acute-phase cytokines such as IL-l, IL-6, and TNF-ex (Fig. 3). Administration of anti-inflammatory agents or antibodies that block trafficking of leukocytes to the lesion diminishes disease expression. 51 With this example, an overzealous acute-phase response is detrimental to the host.



Figure 3. Section of colon (original magnification x 25) from a pig experimentally infected with Brachyspira hyodysenteriae. Note mild edema of the lamina propria (heavy arrow) and many neutrophils. Also, note epithelial necrosis with numerous neutrophils and cellular debris within the intestinal lumen (thin arrow). G = gland lumina. (Courtesy of Robert A. Kunkle, DVM, PhD, and Thaddeus B. Stanton, PhD, National Animal Disease Center, Ames,IA.)

In summary, induction of acute-phase cytokines after invasion of the intestinal mucosa by pathogens is essential for the initiation of an immune response. These cytokines activate endothelial cells of blood vessels, initiating the cascade of events that eventually leads to elaboration of serum factors and leukocytes into gut mucosal tissues. Although proinflammatory cytokines are beneficial and necessary for clearance of certain pathogens, excessive production of IL-l, IL-6, and TNF-a may lead to harmful inflammatory reactions within the gut mucosa.


On inflammation of the gut wall, acute-phase cytokines activate vascular endothelium, causing leakage of serum into the affected area.



Within this serum, specific (e.g., IgG and IgM) and nonspecific (e.g., Creactive protein and the complement protein, C3b) opsonins bind to the surface of foreign organisms or particles, promoting phagocytosis of these antigens by polymorphonuclear cells and macrophages. Serumderived IgG or IgM capable of directly neutralizing virus or toxin (if specific for epitopes on the virus or toxin) is also contained in the sera leaking into the tissues. Antigen-specific, serum-derived IgG or IgM may also activate the classical complement pathway leading to cell lysis (e.g., membrane attack complex) and the production of opsonins (e.g., C3b and iC3b) and anaphylatoxins (e.g., CSa, C3a, and C4a). The alternative complement pathway may also be activated by direct binding of serumderived C3b to microbial surfaces. The production of anaphylatoxins promotes inflammation and chemotaxis of phagocytic cells to the affected area. These responses, although beneficial for the innate clearance of invading organisms, often result in tissue destruction and loss of function. Autoreactive antibody is detected in the sera of a significant percentage of human patients with IBO.23 The most commonly reported antigens reactive with these autoantibodies are perinuclear antineutrophil cytoplasmic proteins, lactoferrin, and colonic epithelial cell antigens (e.g., tropomyosin). Cross reactivity of these autoreactive sera with nonpathogenic E. coli antigens suggests sensitization by the normal intestinal flora and a breach of tolerance. Enteric pathogens such as Campylobacter jejuni, S. typhimurium, and rotavirus also may induce autoimmune reactivity.6, 33, 34 The role of autoreactive antibody in enteric inflammatory diseases of domestic animals, however, is unclear. NEUTROPHILS

Holstein cattle with bovine leukocyte adhesion deficiency have chronic respiratory and enteric infections. 25 The underlying genetic defect of this disorder is a mutation in the gene encoding COt8, resulting in a nonfunctional COt8 molecule. COt8 (coexpressed with C011a, C011b, or C011c as a heterodimer) is an adhesion molecule necessary for the extravasation of neutrophils, Cattle with this defect develop a neutrophilia caused by the inability of these cells to tightly adhere to the blood vessel endothelium. The end result is an inability of neutrophils to traffic to areas of inflammation. Because cattle with this defect are prone to bacterial infections of the intestinal tract, it is postulated that neutrophils are necessary for certain enteric defense mechanisms of cattle. 2 Infection of weanling pigs with S. typhimurium or S, choleraesuis results in multifocal erosions, villous atrophy, and neutrophilic infiltrates of the small intestine and colon. 50 Within these lesions, Salmonella bacilli, although commonly seen within macrophages, are rarely observed within neutrophils. Using mouse models, it has been determined that virulence mechanisms enabling Salmonella spp. growth within macro-



phages do not protect them from killing by neutrophils. 68 It is, therefore, hypothesized that neutrophils are the primary cells involved in host defense against nontyphoid Salmonella and that macrophage invasion is the principal strategy employed to evade host defense mechanisms. Conversely, administration of monoclonal antibodies that prevent extravasation of neutrophils (e.g., anti-CDl8 antibodies) or depletion of neutrophils (e.g., with antibodies specific for murine neutrophils) prevents colitis induced by infection of mice with the swine dysentery pathogen, B. hyodysenteriae. 51 The spirochete still colonizes the mucosa of these mice; thus, it is postulated that disease results from the host response as opposed to direct effects of the bacterium. In this case, the ensuing colitis is likely initiated by acute-phase cytokines produced after neutrophil migration into the ceca of infected mice. Neutrophils are critical effector cells in the host response to bacteria, fungi, and parasites. 53 Phagocytosis and enhanced killing by way of activation of the respiratory burst and release of degradative enzymes from within preformed granules are well-known functional responses by these important cells of the innate immune system. It has only recently been determined that neutrophils are also a rich source of IL12.8 Early IL-12 production biases the ensuing immune response toward a type 1 (e.g., IFN-'Y) response. Early recruitment of IL-12-producing neutrophils into areas of inflamed gut may be critical for the efficient clearance of invading organisms such as Cryptosporidium parvum, M. para, and Salmonella spp. Unfortunately, trafficking of IL-12-producing neutrophils into the lesion likely interferes with the initiation of type 2 responses and may even evoke an excessive inflammatory response. Indeed, many mouse models of IBD are type I-mediated, and neutrophils are likely key inducers of this unfavorable response. REACTIVE METABOLITES

Within inflamed mucosa of human patients with IBD, increased levels of prostaglandins, thromboxane B, and platelet-activating factor are detected. 21 , 30 These lipid mediators of inflammation are produced through the breakdown of membrane phospholipids and induce constriction of smooth muscle (e.g., increased gut peristalsis), activation of vascular endothelial cells, and chemotaxis of leukocytes. Increased levels of mucosal eicosanoids are also detected after infection with Cryptosporidium parvum, rotavirus, and Salmonella spp. and have been implicated in the mechanism of diarrhea induction with each of these diseases. 27, 36,78 As with most mediators of inflammation, production and release of lipid mediators of inflammation are beneficial in the clearance of pathogens; however, excessive production often leads to unnecessary tissue injury. Phagocytic cells use reactive oxygen metabolites and nitric oxide to kill pathogens that have been engulfed into the phagolysosome. Production of nitric oxide by bovine macrophages is greatly enhanced by lipopolysaccharide, IFN-'Y, and TNF-u. 82 Mononuclear cells from cattle



with subclinical paratuberculosis produce superoxide anions and nitric oxide' in response to M. para antigens; however, these substances have little, if any, effect on the intracellular killing of M. para. 80, 81 Nitric oxide is, however, essential for the proficient killing of S. typhimurium and is likely involved in the clearance of C. parvum infection. 37,43 Although generally considered beneficial, excessive amounts of reactive oxygen metabolites and nitric oxide within the intestinal mucosa may be detrimental and have been associated with IBD of human patients.58 CELL-MEDIATED RESPONSES

T lymphocytes provide two effector functions: elaboration of cytokines and cytotoxicity. Cytotoxic responses by T cells located within the intestinal mucosa are essential for the removal of cells infected with intracellular pathogens such as viruses, protozoa, or bacteria. Cytotoxic responses may be antigen specific (e.g., by CD8 +, a~ T-cell receptor [TCR] + cells) or nonspecific (e.g., by natural killer or 'Y& TCR+ cells). Antigen-specific responses generally require prior sensitization and clonal expansion to provide sufficient numbers of specific cells for a potent response, whereas nonspecific responses by definition do not require prior sensitization. It has been determined recently that 'Y& TCR + cells within the intestinal epithelium (e.g., intraepithelial lymphocytes) recognize antigens expressed on the surface of stressed or damaged epithelial cells (e.g., MHC class I chain-related gene A, MHC class I chain-related gene B, and heat shock proteins). Once these cells recognize stressed or damaged cells, they respond either by direct cytolytic action of the affected cell or by the production of cytokines such as IFN-'Y. Because of their location and nature of antigen recognition, 'Y& TCR + intraepithelial lymphocytes are considered an important first line of defense against invading pathogens at the intestinal surface. 29 Cytokines produced by lymphocytes activate macrophages, promote antibody production by B cells, and induce inflammation. Studies with mice have shown that functional subsets of T cells, based on their cytokine production profile, either augment resistance or susceptibility to disease. 46,55 In addition, cytokines produced by antigen-presenting cells, especially monocytes or macrophages, promote a bias in the subset of T cells responding to a particular antigen.48 T-cell responses characterized by the production of IFN-'Y and IL-12, termed type 1 responses, are generally effective against intracellular pathogens such as Mycobacterium spp. Conversely, type 2 responses, characterized by the production of IL-4 and IL-1O, are generally effective for helminth infections. These responses are cross-regulatory in that type 1 responses limit type 2 responses and vice versa.22 Polarized type 1 and type 2 responses by human, pig, and cattle T cells are not as well characterized as are those in mice.9, 12, 40 Studies examining responses of humans to Mycobacterium leprae infection, however, have shown that a polarized type 1 or type 2 immune response dramatically affects the clinical outcome of disease. 69



Thus, the type 1/ type 2 paradigm is not just a phenomenon of the mouse immune system. The most notable function of CD8 + T cells is to lyse cells expressing foreign antigen presented in the context of MHC class I antigens. A clonally expanded population of CD8+ T cells specific for the pathogen of interest is generally required for an efficient response. CD8+ T cells, in addition to their cytotoxic activity, also secrete cytokines (e.g., IFN--y) that activate macrophages and enhance antigen presentation. Like CD4 + T cells, subsets of CD8+ T cells produce discrete cytokine patterns termed Tel and Te2.38 The exact roles of each of these discrete subsets in the response to enteric pathogens are not yet clear; however, CD8 + T cells are capable of producing anti-inflammatory cytokines such as IL-10. Production of IL-10 within the intestinal mucosa would likely dampen inflammation, especially if induced by pathogens evoking type 1 (e.g., IFN--y) responses. Clearance of pathogens by CD8 + T cells resulting in removal of foreign antigen would also result in reduction of inflammation. Clear roles for CD8 + T cells in the response to enteric pathogens are described. For instance, CD8 + T cells are necessary for the proficient clearance of rotavirus and coronavirus infection of mice. 24, 65 Infection of calves with Cryptosporidium parvum leads to an increase in CD8 + T cells at areas of C. parvum colonization; thus, it is hypothesized that CD8 + T cells are involved in the clearance of this protozoan, at least in calves. 1 Likewise, CD8+ T cells have a role in immunity to Eimeria infections of chickens. 39 Salmonella typhimurium infection of mice results in the generation of expanded numbers of CD8 + T cell clones specific for S. typhimurium antigens that are important in both primary and secondary responses to this pathogen. 45 It is probable that most, if not all, intracellular enteric pathogens of food-producing animals induce expansion of antigen-specific CD8 + T cells that playa role in clearance of the pathogen. CD8+ T-cell responses to extracellular pathogens, conversely, are rare. Classically, CD8+ T cells recognize antigen in association with MHC class I antigens located on the surface of antigen-presenting cells, which entails loading of endogenously processed antigen (peptides of approximately 8 to 12 amino acids in length) into the cleft of MHC class I molecules within the endoplasmic reticulum of antigen-presenting cells. Because antigens from extracellular pathogens are processed through the exogenous pathway, it is rare that proteins from these microbes reach the cytosol where they can be processed and presented on MHC class I molecules. Despite these limitations, B. hyodysenteriaespecific CD8 + T cells are detected within the peripheral blood and colonic lymph nodes of pigs vaccinated with a B. hyodysenteriae bacterin or infected with the spirochete. 73 B. hyodysenteriae is a noninvasive, extracellular pathogen. Resolution of infection and protection by vaccination appear to be linked with the appearance of a unique subset of CD8+ T cells within the peripheral blood. 74,75 These cells express CD8 as a homodimer (e.g., CD8exex) as opposed to a heterodimer (e.g., CD8ex~), as occurs on most CD8-expressing cytotoxic T cells. This popu-



lation, although rare in the peripheral blood, is relatively common within the enteric mucosa of many mammalian species. 2B The exact mechanism of protection afforded by these cells is unclear. It is likely that they provide an anti-inflammatory or regulatory function within the colonic mucosa. Vaccination of pigs with the B. hyodysenteriae bacterin, therefore, facilitates the expansion of CD8aa-expressing cells that traffic to the colonic mucosa after infection with B. hyodysenteriae. Once in the colonic mucosa, these cells inhibit inflammation evoked by the spirochete. Thus, vaccination biases the host response to a less inflammatory, more favorable reaction than occurs in nonvaccinated pigs. The ability of type 2 cytokines to regulate inflammation has been shown in several disease models. For example, mucosal inflammatory responses can be inhibited by administering recombinant bacteria that secrete anti-inflammatory cytokines such as IL-1O.61 With this approach, an ensuing immune response to a particular intestinal pathogen would be biased to a type 2 response (e.g., IL-4, IL-5, and IL-13) that is less inflammatory than a type 1 response (e.g., IFN-)' and IL-12) and increases sIgA production. Unfortunately, it may lead to a less favorable outcome if animals become infected with intracellular enteric pathogens such as M. para or Salmonella spp. This method is not likely to be of use in the near future for prevention of inflammatory diseases of foodproducing animals because of the current availability of effective antibiotics and the risk of serious side effects. Increasing concerns with antibiotic resistance, however, warrant exploration of similar approaches as a future alternative. B cells within the lamina propria, Peyer's patches, or other lymphoid aggregates of the gut mucosa provide significant antimicrobial protective mechanisms through antibody production and presentation of antigens to T cells. Human B cells produce, on average, 5 grams of sIgA every day. The large energy demand of chronic immune stimulation (e.g., production of sIgA) has been viewed as an unnecessary drain on average daily gains of food-producing animals, especially pigs. 77 On the contrary, effective maturation of the intestinal immune system requires chronic stimulation by a microbial flora, leading to chronic immune stimulation. Current strategies to restrict unnecessary immune stimulation include strict biocontainment to limit access of pathogens (e.g., transmissible gastroenteritis virus) and housing pigs in clean environments. Another reasonable approach to this problem is to augment intestinal immune maturation of young animals by administration of probiotics that also inhibit colonization of pathogens, thereby managing the microflora to promote maturation and inhibit inflammatory responses that result in diminished performance and increased health costs.54 As stated previously, these organisms may be genetically altered to also deliver anti-inflammatory agents. T-cell immune responses are essential in limiting the severity of paratuberculosis infection. s, 15,49, 70 Antibody production affords little, if any, protection against this intracellular pathogen. Antigen presentation and costimulatory functions by B cells, however, can support T-cell



responses. 20, 70 Antigen presentation/ co stimulation of T cells by B cells often result in type 2 immune responses characterized by secretion of IL-4, IL-5, IL-6, and IL-IO.16,19 Several of these cytokines (e.g., IL-6 and IL-IO) are potent B-cell growth factors.12, 47 Cattle with clinical Johne's disease have excessive numbers of peripheral blood B cells.72 Expansion of B cells may reflect a substantial increase in IL-IO production by M. para-infected macrophages. Increased antigen presentation by the expanded pool of B cells would also favor a type 2 immune response to M. para antigen and result in decreased killing of M. para with progression to clinical disease. With other pathogens, it has been suggested that increased production of type 2 cytokines, especially IL-IO, occurs later in the course of disease to dampen the immune response. 12 A closer examination of the effects of IL-IO on B-cell function may elucidate mechanisms of clinical progression of Johne's disease. SUMMARY

During the past century, research on animal diseases has focused on the characterization of specific etiologies and disease control strategies. Many diseases affecting domestic animals have been successfully controlled using various methods, including vaccination, management, vector control, or antimicrobial agents. A number of microorganisms have proven resistant to these efforts. Control of these organisms requires the development of new strategies. As practitioners and researchers, we need to consider approaches that encompass the entire realm of disease expression from molecular to immune responses and interactions with other functional systems (e.g, endocrine, neurologic, and vascular systems). We need a basic understanding of effective immune responses enabling the tailoring of vaccines to produce the desired response. This tailoring of host responses is augmented by the use of vaccines that use host growth factors, cytokines, or costimulatory molecules to bias the ensuing response. Intestinal microbial flora of food-producing animals can be managed to optimize health and minimize colonization by pathogenic organisms, especially zoonotic agents. New systems for the delivery of cytokines and other factors that favor optimal intestinal health and homeostasis need to be researched and evaluated. With time, it is likely that our clients and the consumers will be less tolerant of antibiotic usage. They will be more aware of the zoonotic potential of many microbes that colonize food animals. Food safety issues will be a continuing concern, as will the protection of our water supply from contamination from feedlots and pasture runoff. We are in the dawn of a new century, and, it is hoped, a new era of discovery of enteric disease pathogenesis and control. ACKNOWLEDGMENTS The author thanks Dr. Mitchell Palmer and Dr. Jim Harp at the National Animal Disease Center and Dr. Michael Wannemuehler at Iowa State University, College of Veterinary Medicine, in Ames, Iowa for review of this article.



References 1. Abrahamsen MS: Bovine T cell responses to Cryptosporidium parvum infection. Int J

Parasitol 28:1083-1088, 1998 2. Ackermann MR, Kehrli ME Jr, Laufer JA, et al: Alimentary and respiratory tract lesions in eight medically fragile Holstein cattle with bovine leukocyte adhesion deficiency (BLAD). Vet Pathol 33:273-281, 1996 3. Adams JL, Czuprynski CJ: Ex vivo induction of lNF-alpha and IL-6 mRNA in bovine whole blood by Mycobacterium paratuberculosis and mycobacterial cell wall components. Microb Pathog 19:19-29, 1995 4. Alzuherri HM, Woodall CJ, Clarke CJ: Increased intestinal TNF-alpha, IL-1 beta and IL6 expression in ovine paratuberculosis. Vet Immunol Immunopathol 49:331-345, 1996 5. Appelberg R, Castro AG, Pedrosa J, et al: Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and dependent phases of Mycobacterium avium infection. Infect Immun 62:3962-3971, 1994 6. Asbury AK: New concepts of Guillain-Barre syndrome. J Child NeuroI15:183-191, 2000 7. Bailey M, Hall L, Bland PW, et al: Production of cytokines by lymphocytes from spleen, mesenteric lymph node, and intestinal lamina propria of pigs. Immunology 82:577-583, 1994 8. Bliss SK Butcher BA, Denkers EY: Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection. J Immunol 165:4515-4521, 2000 9. Bloom BR, Modlin RL, Salgame P: Stigma variations: Observations on suppressor T cells and leprosy. Annu Rev Immunol 10:453-488, 1992 10. Boismenu R, Havran WL: Modulation of epithelial cell growth by intraepithelial gamma delta T cells. Science 266:1253-1255, 1994 11. Bomsel M, Heyman M, Hocini H, et al: Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HlV envelope protein IgA or IgM. Immunity 9:277-287, 1998 12. Brown WC, Estes OM: Type 1 and type 2 responses in cattle and their regulation. In Schijns VECJ, Horzinek MC (eds): Cytokines in Veterinary Medicine. Carbondale, IL, CABI International, 1997, pp 15-33 13. Cario E, Rosenberg 1M, Brandwein SL, et al: Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 164:966--972, 2000 14. Cheville NF: Ultrastructural pathology: An introduction to interpretation. Ames, lA, Iowa State University Press, 1994, pp 429-479 15. Chiodini RJ, Davis We: The cellular immunology of bovine paratuberculosis: The predominant response is mediated by cytotoxic gamma/delta T lymphocytes which prevent CD4 + activity. Microb Pathog 13:447-463, 1992 16. Conradt P, Kaufmann SHE: Impact of antigen-presenting cells on cytokine profiles of human Th clones established after stimulation with Mycobacterium tuberculosis antigens. Infect Immun 63:2079-2081, 1995 17. Cotran RS, Kumar V, Robbins SL: Robbins' Pathologic Basis of Disease, ed 5. Philadelphia, WB Saunders, 1994, pp 51-93 18. Dreau 0, Lalles JP, Toullec R, et al: B and T lymphocytes are enhanced in the gut of piglets fed heat-treated soybean proteins. Vet Immunol Immunopathol 47:69-79, 1995 19. Duncan DO, Swain SL: The role of antigen-presenting cells in the polarized development of helper T cell subsets: Evidence for differential cytokine production by THO cells in response to antigen presentation by B cells and macrophages. Eur J Immunol 24:2506-2514, 1994 20. Dunlap NE, Briles DE: Immunology of tuberculosis. Med Clin North Am 77:12351251, 1993 21. Eliakim R, Karmeli F, Razin E, et al: Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. Gastroenterology 95:1167-1172, 1988 22. Fernandez Botan R, Sanders VM, Mosmann TR, et al: Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells. J Exp Med 168:543-558, 1988



23. Fiocchi C: The immune system in inflammatory bowel disease. Acta Gastro-Enterologica Belgica LX:156-162, 1997 24. Franco MA, Tin C, Rott LS, et al: Evidence for CD8 + T-cell immunity to murine rotavirus in the absence of perforin, fas, and gamma interferon. J Virol71:479-486, 1997 25. Gilbert RO, Rebhun WC, Kim CA, et al: Clinical manifestations of leukocyte adhesion deficiency in cattle: 14 cases (1977-1991). J Am Vet Med Assoc 202:445-449, 1993 26. Greer JM, Wannemuehler MJ: Pathogenesis of Treponema hyodysenteriae: Induction of interleukin-1 and tumor necrosis factor by a treponemal butanol/water extract (endotoxin). Microb Pathog 7:279-288, 1989 27. Grondahl ML, Jensen GM, Nielsen CG, et al: Secretory pathways in Salmonella typhimurium-induced fluid accumulation in the porcine small intestine. J Med MicrobioI47:151157, 1998 28. Guy-Grand D, Vassalli P: Gut intraepitheliallymphocytes. Curr Opin Immunol 5:247252, 1993 29. Haas W, Pereira P, Tonegawa S: Gamma/delta cells. Annu Rev Immunol 11:637-685, 1993 30. Hawkey CJ, Karmeli F, Rachmilewitz D: Imbalance of prostacyclin and thromboxane synthesis in Crohn's disease. Gut 24:881-885, 1993 31. Hein WR, Mackay CR: Prominence of ')'8 T-cells in the ruminant immune system. Immunol Today 12:30-34, 1991 32. Hermiston ML, Gordon JI: Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 270:1203-1207, 1995 33. HoI C, Bloembergen P, van Dijk H: Bacterium-induced autoimmune reactivity. Autoimmunity 15:49-54, 1993 34. Honeyman MC, Coulson BS, Stone NL, et al: Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 49:1319-1324, 2000 35. Kilshaw pJ, Sissons JW: Gastrointestinal allergy to soybean protein in preruminant calves: Antibody production and digestive disturbances in calves fed heated soybean flour. Res Vet Sci 27:361-365, 1979 36. Laurent F, Kagnoff MF, Savidge TC, et al: Human intestinal epithelial cells respond to Cryptosporidium parvum infection with increased prostaglandin H synthase 2 expression and prostaglandin E2 and F2alpha production. Infect Immun 66:1787-1790, 1998 37.. Leitch GJ, He Q: Reactive nitrogen and oxygen species ameliorate experimental cryptosporidiosis in the neonatal BALB/c mouse model. Infect Immun 67:5885-5891, 1999 38. Li L, Sad S, Kagi D, et al: CD8Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions. J Immunol 158:4152-4161, 1997 39. Lillehoj HS, Lillehoj EP: Avian coccidiosis: A review of acquired intestinal immunity and vaccination strategies. Avian Dis 44:408-425, 2000 40. Mansfield LS, Urban JF, Holley-Shanks RR, et al: Construction of internal cDNA competitors for measuring IL-10 and IL-12 cytokine gene expression in swine. Vet Immunol Immunopathol 65:63-74, 1998 41. Mansfield LS, Urban JF: The pathogenesis of necrotic proliferative colitis in swine is linked to whipworm-induced suppression of mucosal immunity to resident bacteria. Vet Immunol Immunopathol 50:1-17, 1996 42. Mashimo H, Wu DC, Podolsky DK, et al: Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 274:262-265, 1996 43. Mastroeni P, Vazquez-Torres A, Fang FC, et al: Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis: II. Effects on microbial proliferation and host survival in vivo. J Exp Med 192:237248,2000 44. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 88:394-397, 1997 45. Mittrucker HW, Kaufmann SH: Immune response to infection with Salmonella typhimurium in mice. J Leukoc BioI 67:457-463, 2000 46. Mosmann TR, Coffman RL: TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173, 1989 47. Mosmann TR: Properties and functions of interleukin 10. Adv ImmunoI56:1-26, 1994



48. Muraille E, Leo 0: Revisiting the Thl/Th2 paradigm. Scand J ImmunoI47:1-9, 1998 49. Orme 1M, Furney SK, Roberts AD: Dissemination of enteric Mycobacterium avium infections in mice rendered immunodeficient by thymectomy and CD4 depletion or by prior infection with murine AIDS retrovirus. Infect Immun 60:4747-4753, 1992 50. Reed WM, Olander HJ, Thacker HL: Studies on the pathogenesis of Salmonella typhimurium and Salmonella choleraesuis var kunzendorf infection in weanling pigs. Am J Vet Res 47:75-83, 1986 51. Sacco RE, Hutto DL, Waters WR, et al: Reduction in inflammation following blockade of CD18 or CD29 adhesive pathways during the acute phase of a spirochetal-induced colitis in mice. Microb Pathog 29:289-299, 2000 52. Sartor B: Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis, and experimental intestinal inflammation. In Kirsner JB, Shorter RG (eds): Inflammatory Bowel Disease, ed 4. Baltimore, Williams and Wilkins, 1995, p 96 53. Seder RA, Gazzinelli RT: Cytokines are critical in linking the innate and adaptive immune responses to bacterial, fungal, and parasitic infection. Adv Intern Med 44:353388, 1999 54. Shanahan F: Immunology: Therapeutic manipulation of gut flora. Science 289:13111312,2000 55. Sher A, Gazzinelli RT, Oswald IP, et al: Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev 127:183-204, 1992 56. Simmonds NJ, Rampton DS: Inflammatory bowel disease-A radical view. Gut 34:865868, 1993 57. Stabel JR: Cytokine secretion by peripheral blood mononuclear cells from cows infected with Mycobacterium paratuberculosis. Am J Vet Res 61:754-760, 2000 58. Stabel 1J, Fedorka-Cray PJ, Gray JT: Tumor necrosis factor-alpha production in swine after oral or respiratory challenge exposure with live Salmonella typhimurium or Salmonella choleraesuis. Am J Vet Res 56:1012-1018, 1995 59. Stallmach A, Strober W, MacDonald T, et al: Induction and modulation of gastrointestinal inflammation. Immunol Today 19:438-441, 1998 60. Stavnezer J: Regulation of antibody production and class switching by TGF-(3. J Immunology 155:1647-1651, 1999 61. Steidler L, Hans W, Schotte L, et al: Treatment of murine colitis by Lactococcus lactis secreting interleukin-l0. Science 289:1352-1355, 2000 62. Stevens C, Walz G, Singaram C, et al: Tumor necrosis factor-alpha, interleukin-l beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 37:818-826, 1992 63. Stokes CR, Haverson K, Bailey M: Antigen presenting cells in the porcine gut. Vet Immunol Immunopathol 54:171-177, 1996 64. Strober W, Ehrhardt RO: Chronic intestinal inflammation: An unexpected outcome in cytokine or T cell receptor mutant mice. Cell 75:203-205, 1993 65. Sussman M, Shubin R, Kyuwa S, et al: T cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system. J Virol 63:3051-3056, 1989 66. Tomioka H, Sato K, Maw WW, et al: The role of tumor necrosis factor, interferon-,,!, transforming growth factor-(3, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by Mycobacterium avium complex infection. J Leukoc Bioi 58:704-712, 1995 67. Van Dijk JE, Fledderus A, Mouwen JM, et al: Gastrointestinal food allergy and its role in large domestic animals. Vet Res Commun 12:47-59, 1988 68. Vassiloyanakopoulos AP, Okamoto S, Fierer J: The crucial role of polymorphonuclear leukocytes in resistance to Salmonella dublin infections in genetically susceptible and resistant mice. Proc Nat! Acad Sci USA 95:7676-7681, 1998 69. Verhagen CE, Wierenga EA, Buffing AA, et al: Reversal reaction in borderline leprosy is associated with a polarized shift to type I-like Mycobacterium leprae T cell reactivity in lesional skin. J Immunol 159:4474-4483, 1997 70. Vordermeier HM, Venkataprasad N, Harris DP, et al: Increase of tuberculous infection in the organs of Bcell-deficient mice. Clin Exp ImmunoI106:312-316, 1996 71. Wallace FM, Mach AS, Keller AM, et al: Evidence for Clostridium perfringens enterotoxin


72. 73. 74. 75. 76. 77. 78. 79. 80. 81. 82.


(CPE) inducing a mitogenic and cytokine response in vitro and a cytokine response in vivo. Curr Microbiol 38:96-100, 1999 Waters WR, Stabel JR, Sacco RE, et al: Antigen-specific B cell unresponsiveness induced by chronic Mycobacterium avium subsp. Paratuberculosis infection of cattle. Infect Immun 67:1593-1598, 1999 Waters WR, Sacco RE, Dom AD, et al: Systemic and mucosal immune responses of pigs to parenteral immunization with a pepsin-digested Serpulina hyodysenteriae bacterin. Vet Immunol ImmunopathoI69:75-87, 1999 Waters WR, Pesch BA, Hontecillas R, et al: Cellular immune responses of pigs induced by vaccination with either a whole cell sonicate or pepsin-digested Brachyspira (Serpulina) hyodysenteriae bacterin. Vaccine 18:711-719, 1999 Waters WR, Hontecillas R, Sacco RE, et al: Antigen-specific proliferation of porcine CD8aa cells to an extracellular bacterial pathogen. Immunology 101:333-341, 2000 Whipp SC, Robinson 1M, Harris DL, et al: Pathogenic synergism between Treponema hyodysenteriae and other selected anaerobes in gnotobiotic pigs. Infect Immun 26:10421047, 1979 Williams NH, Stahly TS, Zimmerman DR: Effect of level of chronic immune system activation on the growth and dietary lysine needs of pigs fed from 6 to 112 kg. J Anim Sci 75:2481-2496, 1997 Yamashiro Y, Shimizu T, Oguchi S, et al: Prostaglandins in the plasma and stool of children with rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 9:322-327, 1989 Xavier RJ, Podolsky DK: How to get along-Friendly microbes in a hostile world. Science 289:1483-1484, 2000 Zurbrick BG, Czuprynski CJ: Ingestion and intracellular growth of Mycobacterium paratuberculosis within bovine blood monocytes and monocyte-derived macrophages. Infect Immun 55:1588-1593, 1987 Zurbrick BG, Follett DM, Czuprynski CJ: Cytokine regulation of the intracellular growth of Mycobacterium paratuberculosis in bovine monocytes. Infect Immun 56:16921697, 1988 Zhao BY, Collins MT, Czuprynski CJ: Induction of L-arginine-dependent production of nitric oxide in bovine monocytes by interferon gamma and lipopolysaccharide. Res Vet Sci 60:190-192, 1996

Address reprint requests to W. Ray Waters, DVM, PhD National Animal Disease Center PO Box 70 2300 Dayton Avenue Ames, IA 50010 e-mail: [email protected]